🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT07527559
Starting soon Not applicable

Fuzzle System for Appetite Control and Weight Management

NCT07527559 · tracked via the Priya Life Science USA tracker
Sponsor
Fuzzle Operating Co.
Phase
Not applicable
Started
2026-05-01
Last updated
2026-04-17

Condition(s) studied

Obesity & Overweight

Investigational drug(s) / intervention(s)

Fuzzle Intraoral DeviceLifestyle Management

Fuzzle Intraoral Device: The Fuzzle intraoral device is a custom-fabricated, removable oral appliance designed for daytime wear as an adjunct to weight management. The device is created from dental impressions to ensure a patient-specific fit. Participants are instructed to wear the device during waking hours, excluding meals and oral hygiene. The device is intended to modulate oral sensory input within the stomatognathic system, with the goal of influencing eating-related behaviors, including reductions in snacking frequency and alterations in meal patterns. It is non-invasive, reversible, and used in a home setting under provider supervision.

Lifestyle Management: Participants receive standardized lifestyle management including dietary guidance, caloric targets based on estimated energy expenditure, and structured behavioral counseling. Participants track food intake using a mobile application with weekly check-ins to reinforce adherence.

Study summary

This study is evaluating whether the Fuzzle intraoral device can help adults with obesity lose weight when used alongside standard lifestyle counseling.

Participants in this study will receive guidance on diet and behavior to support weight loss. Some participants will also receive the Fuzzle device, a custom-made removable oral appliance worn during the day.

The study will compare weight loss outcomes between participants who use the Fuzzle device and those who follow lifestyle counseling alone over a 16-week period.

Researchers will also explore whether use of the device increases the number of participants who achieve meaningful weight loss and may evaluate changes in selected metabolic markers in a subset of participants.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Adults aged 18-65 years * Body mass index (BMI) ≥30 kg/m² at screening * Willing and able to provide informed consent * Willing to comply with study visits and procedures * Willing to participate in standardized lifestyle counseling Exclusion Criteria: * Participation in another weight-loss clinical study within 90 days * Pregnancy, breastfeeding, or intent to become pregnant during the study period * History of eating disorders or uncontrolled psychiatric illness * Oral or dental conditions preventing safe device use * Current use of prescription or over-the-counter weight-loss medications * A1C \>8.0% at screening (glycemic subset exclusion only) * Unstable diabetes medication regimen (glycemic subset exclusion only) * Any medical condition that, in the investigator's judgment, would interfere with safe participation

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
DM Clinical Research Bradenton Florida

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07527559 on ClinicalTrials.gov ↗ ← All trials in the USA